Retrospective Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Jun 28, 2017; 23(24): 4407-4415
Published online Jun 28, 2017. doi: 10.3748/wjg.v23.i24.4407
Table 5 Analysis of risk factors associated with occurrence of metachronous carcinoma n (%)
Control group(n = 488)Metachronous carcinoma group (n = 27)Univariate analysisP valueMultivariate analysis
OR95%CIP value
Sex0.0050.027
Male328 (67.2)25 (92.6)5.2381.211-22.661
Female160 (32.8)2 (7.4)1.000
Age0.671
≥ 60343 (70.3)18 (66.7)
< 60145 (29.7)9 (33.3)
Dysplasia0.0240.023
Low grade417 (85.5)18 (66.7)1.000
High grade71 (14.5)9 (33.3)2.7411.148-6.546
En bloc resection179 (37.7)9 (33.3)0.839
Intestinal metaplasia155 (31.8)9 (33.3)0.0052.6471.165-6.0120.020
Atrophy0.0100.065
Closed445 (91.2)20 (74.1)1.000
Open43 (8.8)7 (25.9)2.4920.946-6.569
Resection method0.503
EMR359 (73.6)18 (66.7)
ESD129 (26.4)9 (33.3)
Endoscopic findings0.546
Elevated326 (66.8)21 (77.8)
Flat96 (19.7)3 (11.1)
Depressed66 (13.5)3 (11.1)
Location1.000
Lower324 (66.4)17 (63.0)
Mid156 (32.0)9 (33.3)
Upper8 (1.6)0 (0.0)
Size0.532
≤ 3334 (68.4)17 (63.0)
> 3154 (31.6)10 (37.0)
Helicobacter Pylori infection385 (78.9)20 (74.1)0.629